Development, License Deal For BSG005
25/09/2023 06:46
Sept 25 (Reuters) - Biosergen AB BIOSGN.ST :
* BIOSERGEN AND ALKEM LABORATORIES LTD COLLABORATES TO DEVELOP ANTI-INFECTIVE FOR SEVERE
FUNGAL
INFECTIONS
* SIGNING OF A CO-DEVELOPMENT AND LICENSE AGREEMENT FOR BSG005, AN INNOVATIVE POLYENE
MACROLIDE,
THROUGH PHASE II AND PHASE III TRIALS FOR SALE IN INDIAN MARKET
Source text for Eikon: ID:nWkr8VV3kr
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million